Share this post on:

Name :
HLA-DRA antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
HLA-DRA Rabbit Polyclonal antibody. Positive IHC detected in human tonsil.

Tested applications :
ELISA, IHC

Species reactivity :
human, mouse, rat; other species not tested.

Alternative names :
HLA-DRA antibody; HLA DRA1 antibody; HLA DRA antibody; MHC class II antigen DRA antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of HLA-DRA recombinant protein (Accession Number: NM_019111). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: IHC: 1:20-1:200

Background :
HLA-DRA represents major histocompatibility complex, class II, DR alpha

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 405-conjugated AffiniPure Goat Anti-Mouse IgG H&L
Phospho-Smad1 (Ser463/Ser465) Antibody
N-Cadherin Antibody: N-Cadherin Antibody is a non-conjugated and Mouse origined monoclonal antibody about 100 kDa, targeting to N-Cadherin. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Gardos- Channel